- Business Wire•last monthCEL-SCI Announces Closing of Public Offering and Receives Audit Opinion with Going Concern Explanation
CEL-SCI Corporation announced today that it has received net proceeds of $3,702,760 and expects to receive the remaining $75,000 this week from its previously announced public offering of common stock and warrants, after deducting estimated placement agent discounts and commissions and estimated offering expenses payable by the Company.
- Associated Press•last month
The Vienna, Virginia-based company said it had a loss of 1 cent per share. The cancer immunotherapy company posted revenue of $101,000 in the period. For the year, the company reported that its loss narrowed ...
- Business Wire•last month
CEL-SCI Corporation reported financial results today for the fiscal year ended September 30, 2016. The Company also reported key clinical and corporate developments achieved during and subsequent to fiscal 2016.
CVM : Summary for Cel-Sci Corporation Common Stoc - Yahoo Finance
CEL-SCI Corporation (CVM)
NYSE MKT - NYSE MKT Delayed Price. Currency in USD
Add to watchlist
|Day's Range||0.11 - 0.11|
|52 Week Range||0.06 - 0.66|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||-0.60|
|Dividend & Yield||0.00 (0.00%)|
|1y Target Est||N/A|